Gottlieb, Alice B, Bruce Strober, Diamant Tha?i, Kenneth Gordon, Sundeep Kundu, Renata Kisa, Lan Wei, Subhashis Banerjee, and Joseph Merola. “BMS-986165, an Oral, Selective TYK2 Inhibitor, in the Treatment of Moderate to Severe Psoriasis As Assessed by the Static Physician’s Global Assessment (sPGA)/Body Surface Area (BSA) Composite Tool (sPGAxBSA), a Clinically Useful Alternative to PASI”. SKIN The Journal of Cutaneous Medicine 4, no. 5 (September 2, 2020): s29. Accessed August 12, 2022. https://www.jofskin.org/index.php/skin/article/view/978.